Jan 5 (Reuters) - Metagenomi Technologies, a genetic medicines company backed by Bayer Healthcare and Moderna , filed for an initial public offering in the United States on Friday. (Reporting by Niket Nishant in Bengaluru; Editing by Pooja Desai)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
148.4 USD | -0.13% | +2.10% | +49.21% |
Jun. 10 | Health Care Up on Defensive Bias -- Health Care Roundup | DJ |
Jun. 10 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
148.4 USD | -0.13% | +2.10% | 56.95B | ||
27.08 EUR | -1.44% | -4.43% | 29B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.21% | 56.95B | |
+39.98% | 40.26B | |
-6.86% | 39.32B | |
-4.42% | 28.37B | |
+12.00% | 26.45B | |
-18.27% | 19.41B | |
+29.57% | 12.54B | |
+25.41% | 12.21B | |
-0.35% | 12.15B | |
-10.99% | 11.05B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna-backed genetic drugs firm Metagenomi files for US IPO